New Drugs and Evolving Treatment Patterns in Lupus Nephritis: How Nephrologists and Rheumatologists Are Responding Differently to New Treatment Options

被引：0
|
作者：
Hurtado, Tucker B. [1 ]
Robinson, Jennifer [1 ]
Rex, Ryan [1 ]
机构：
[1] Spherix Global Insights, Spherix Adv Analyt Grp, Exton, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PO1435
引用
收藏
页码：454 / 454
页数：1
相关论文
共 50 条
  • [41] New approaches for the treatment of lupus nephritis in the 21st century: from the laboratory to the clinic
    Ripoll, Elia
    Merino, Ana
    Grinyo, Josep M.
    Torras, Juan
    IMMUNOTHERAPY, 2013, 5 (10) : 1089 - 1101
  • [42] New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab
    Staveri, Chrysanthi
    Karokis, Dimitrios
    Liossis, Stamatis-Nick C.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 46 (06) : 788 - 790
  • [43] New drugs for the treatment of diabetes mellitus - Part I: Thiazolidinediones and their evolving cardiovascular implications
    McGuire, Darren K.
    Inzucchi, Silvio E.
    CIRCULATION, 2008, 117 (03) : 440 - 449
  • [44] New Treatment Options in Chronic Hepatitis B: How Close Are We to Cure?
    Korkmaz, Pinar
    Asan, Ali
    Karakecili, Faruk
    Tekin, Sueda
    Demirturk, Nese
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2023, 5 (04): : 267 - 280
  • [45] JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple options
    Stein, Brady L.
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 292 - 299
  • [46] Are New Treatment Options Shifting How and When We Treat Waldenstrom Macroglobulinemia?
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (05) : 16 - 19
  • [47] New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents
    Toussirot, Eric
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (03) : 275 - 282
  • [48] Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms
    Nicholas J. Short
    Hagop Kantarjian
    Elias Jabbour
    Leukemia, 2021, 35 : 3044 - 3058
  • [49] Optimizing the treatment of acute lymphoblastic leukemia in younger and older adults: new drugs and evolving paradigms
    Short, Nicholas J.
    Kantarjian, Hagop
    Jabbour, Elias
    LEUKEMIA, 2021, 35 (11) : 3044 - 3058
  • [50] Autosomal Dominant Polycystic Kidney Disease: New Treatment Options and How to Test Their Efficacy
    Wuethrich, Rudolf P.
    Serra, Andreas L.
    Kistler, Andreas D.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (05): : 380 - 387
12345